Oncorus Inc (ONCR)

9.53 -0.01  -0.10% NASDAQ Sep 23, 16:00 9.53 0.00  0.00% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All ONCR News

News

View All Events

Events

Date Type Description
11/11/2021 Earnings Results Q3 2021 Earnings Results
08/04/2021 Earnings Results Q2 2021 Earnings Results
06/16/2021 13:00 EST AGM 2020 Annual General Meeting
05/04/2021 Earnings Results Q1 2021 Earnings Results
03/10/2021 Earnings Results Q4 2020 Earnings Results
11/11/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Oncorus Inc is a clinical stage biopharmaceutical company focused on developing viral immunotherapies to transform outcomes for cancer patients. The company is in the process of developing intratumorally and intravenously administered product candidates designed to selectively attack and kill tumor cells and stimulate multiple arms of the immune system against tumors. Its pipeline product includes ONCR-177; ONCR-GBM; Coxsackievirus A21 and Seneca Valley Virus.
  • URL: https://www.oncorus.com
  • Investor Relations URL: https://investors.oncorus.com/
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: N/A
  • Next Earnings Release: Nov. 11, 2021
  • Last Earnings Release: Aug. 04, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.